How South Korea Brought Hypertension Under Control

South Korea has emerged as one of the few countries in the world to have successfully addressed hypertension at a national scale, according to a World Report published in The Lancet. The piece positions the country as a potential reference point for other nations where high blood pressure remains a significant public health burden.

A Sustained Policy Effort

The report attributes South Korea's progress not to a single intervention but to coordinated health policy sustained over roughly 15 years. The findings suggest that consistency and long-term commitment at the governmental level were central to the outcome — a combination that has proved difficult to replicate elsewhere.

High blood pressure is widely recognised as a leading contributor to cardiovascular disease globally, yet most countries have struggled to move the needle on control rates at a population level. South Korea's trajectory, as described in The Lancet, stands in contrast to that broader pattern.

A Model for Other Nations?

The report frames South Korea's experience as a possible template for countries still grappling with hypertension as a systemic challenge. While the specific policy mechanisms behind the achievement are not detailed in full within the World Report summary, the emphasis falls on the concerted and sustained nature of the effort rather than any single programme or initiative.

The piece was authored by Faith McLellan and appears in The Lancet's World Report section, which typically examines health policy developments and public health trends from around the globe.

Whether the South Korean approach can be meaningfully adapted by other health systems — each with different infrastructure, funding models, and population dynamics — remains an open question. The Lancet report does not draw direct comparisons with specific countries, but its framing implies that the lessons may have broader relevance.